Prednisolone
Information
- Drug Name
- Prednisolone
- Description
- Entry(CIViC)
- 3
CIViC
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04227483 | Active, not recruiting | Phase 2/Phase 3 | Deflazacort vs. Prednisolone in Acute-stage ABPA | January 15, 2020 | December 2024 |
| NCT04161898 | Active, not recruiting | Phase 3 | A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK) | February 4, 2020 | August 30, 2027 |
| NCT04098718 | Active, not recruiting | Phase 2 | Acute Exacerbations Treated With BenRAlizumab (The ABRA Study) | March 29, 2021 | November 19, 2024 |
| NCT03936517 | Active, not recruiting | Phase 3 | Safety and Efficacy of Prednisolone in Adrenal Insufficiency Disease (PRED-AID Study) | July 31, 2019 | February 1, 2025 |
| NCT03792256 | Active, not recruiting | Phase 1 | Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) | April 11, 2019 | June 30, 2025 |
| NCT03586999 | Active, not recruiting | Phase 1/Phase 2 | Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas | November 7, 2018 | December 2024 |
| NCT02889523 | Active, not recruiting | Phase 1/Phase 2 | Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy | October 2016 | April 2026 |
| NCT04034095 | Active, not recruiting | A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan | July 8, 2019 | October 8, 2025 | |
| NCT03962894 | Active, not recruiting | Phase 4 | Early Administration of Steroids in the Ambulance Setting | April 1, 2019 | December 31, 2024 |
| NCT00268476 | Active, not recruiting | Phase 2/Phase 3 | Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy | July 8, 2005 | December 2030 |
| NCT02881086 | Active, not recruiting | Phase 3 | Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | August 2016 | July 2025 |
| NCT04314193 | Active, not recruiting | Phase 4 | Effectiveness of Methotrexate Versus Prednisolone as First-line Therapy for Pulmonary Sarcoidosis | June 1, 2020 | July 2026 |
| NCT04914741 | Active, not recruiting | Phase 1/Phase 2 | A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL) | June 29, 2021 | July 2025 |
| NCT03368664 | Active, not recruiting | Phase 3 | A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT | October 24, 2017 | December 2025 |
| NCT03210688 | Active, not recruiting | Phase 4 | Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy | May 1, 2018 | May 31, 2025 |
| NCT02828358 | Active, not recruiting | Phase 2 | Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement | April 1, 2017 | September 22, 2024 |
| NCT00555607 | Active, not recruiting | N/A | Longitudinal Assessment of Clinical Course and BIOmarkers in Severe Chronic AIRway Disease | March 2002 | December 2026 |
| NCT00198523 | Completed | Phase 3 | A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte | July 2005 | October 2005 |
| NCT00198991 | Completed | Phase 4 | German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) | April 2003 | June 30, 2013 |
| NCT00213252 | Completed | Phase 2 | Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma | September 2005 | February 2008 |
| NCT00259779 | Completed | Phase 3 | Comparison Between Symbicort® and Prednisolone in COPD | September 2005 | July 2007 |
| NCT00261820 | Completed | Phase 4 | Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients | January 2005 | |
| NCT00276757 | Completed | N/A | Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis | April 2001 | June 2013 |
| NCT00299013 | Completed | Phase 3 | Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis | March 2006 | April 2008 |
| NCT00312325 | Completed | Phase 4 | Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans | July 2005 | August 2005 |
| NCT00312520 | Completed | Phase 3 | Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of Infancy | July 2002 | June 2005 |
| NCT00662298 | Completed | Phase 4 | Prednisolone Pharmacokinetics in Severe Asthma | June 2011 | January 2013 |
| NCT00002576 | Completed | Phase 3 | Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma | November 1992 | January 2001 |
| NCT00002700 | Completed | Phase 3 | Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia | August 1995 | |
| NCT00002757 | Completed | Phase 3 | TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma | June 2001 | October 2009 |
| NCT00003421 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease | June 1998 | November 2005 |
| NCT00004218 | Completed | Phase 3 | Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia | October 1999 | July 2007 |
| NCT00004357 | Completed | Phase 2 | Absorption of Corticosteroids in Children With Juvenile Dermatomyositis | September 1997 | February 2008 |
| NCT00004430 | Completed | N/A | Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization | September 1994 | September 1998 |
| NCT00005867 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | January 1998 | August 2007 |
| NCT00015873 | Completed | Phase 3 | Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia | May 1999 | December 2009 |
| NCT00057421 | Completed | Phase 2 | Tuberculosis in HIV Infected Patients in Uganda | November 1998 | September 2002 |
| NCT00079105 | Completed | Phase 2 | A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years | January 2004 | December 2010 |
| NCT00115700 | Completed | Phase 3 | Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma | February 2000 | August 2018 |
| NCT00130195 | Completed | Phase 2 | Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) | September 2002 | May 2008 |
| NCT00134693 | Completed | Phase 2 | A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis | June 21, 2005 | August 3, 2006 |
| NCT00135122 | Completed | Phase 3 | Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache | September 2003 | January 2007 |
| NCT00148746 | Completed | N/A | Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis | May 2004 | March 2008 |
| NCT00337623 | Completed | N/A | Impact of Systemic Corticosteroid Therapy on Lens Transparency and Quantification of Lens Autofluorescence. | June 2000 | July 2006 |
| NCT00338793 | Completed | N/A | Corticosteroids in the Treatment of Tuberculous Pleurisy | July 2006 | August 2008 |
| NCT00379574 | Completed | Phase 1/Phase 2 | Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL | September 2006 | January 2011 |
| NCT00379730 | Completed | Phase 1 | Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) | March 21, 2006 | May 3, 2007 |
| NCT00379990 | Completed | Phase 2 | A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days. | January 2006 | December 2007 |
| NCT00380133 | Completed | Phase 1 | Study of SB681323 and Prednisolone on Biomarkers in COPD (Chronic Obstructive Pulmonary Disease) Patients | June 2005 | April 2006 |
| NCT00384306 | Completed | Phase 1 | Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary Disease | June 2004 | January 2006 |
| NCT00400946 | Completed | Phase 3 | Treatment of Acute Lymphoblastic Leukemia in Children | April 2005 | June 2019 |
| NCT00433459 | Completed | Phase 3 | Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma | January 2007 | January 2013 |
| NCT00433940 | Completed | Immune Suppression Of Infants Treated With Steroids | October 2006 | July 2010 | |
| NCT00445081 | Completed | Phase 4 | Prednisolone vs. Ciclosporine in Severe Atopic Eczema | March 2007 | January 2010 |
| NCT00451594 | Completed | Phase 3 | High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP | September 2005 | December 2010 |
| NCT00481819 | Completed | Phase 3 | A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation | July 2007 | March 2009 |
| NCT00498797 | Completed | Phase 2 | E3-Hormone Refractory Prostrate Cancer Taxotere Combination | December 2005 | September 2008 |
| NCT00513955 | Completed | Phase 2 | Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma | June 2006 | October 2014 |
| NCT00526409 | Completed | Phase 4 | LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia | June 2005 | October 2014 |
| NCT00551707 | Completed | Phase 2 | Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis | October 2007 | January 2009 |
| NCT00554918 | Completed | Phase 2 | Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy | February 2005 | June 2013 |
| NCT00575406 | Completed | Phase 2 | Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma | December 2007 | January 2012 |
| NCT00618501 | Completed | Phase 2 | Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | October 2005 | January 2009 |
| NCT00666484 | Completed | Phase 2 | Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma | March 2008 | September 2012 |
| NCT00678327 | Completed | Phase 3 | Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | August 29, 2008 | May 1, 2024 |
| NCT00744224 | Completed | N/A | PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide | February 2009 | January 2010 |
| NCT00753103 | Completed | Phase 2 | Anti-Cytokine Therapy for Vasculitis | January 2003 | July 2006 |
| NCT00788749 | Completed | Phase 4 | Medical Polypectomy and Predictors of Response | May 2004 | November 2008 |
| NCT00810849 | Completed | Phase 3 | A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis | December 2008 | August 2014 |
| NCT00812825 | Completed | Phase 1 | A Phase 1 Multiple-Dose Escalation and Single Dose (Tablet) Study of PF-04171327 in Healthy Volunteers | January 2009 | July 2009 |
| NCT00822809 | Completed | Phase 3 | CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers | December 2008 | April 2011 |
| NCT00836810 | Completed | Phase 2/Phase 3 | Timed Release Tablet Prednisone in Polymyalgia Rheumatica | October 2009 | March 2011 |
| NCT00919542 | Completed | Phase 2 | Ciclosporin in the Management of New Erythema Nodosum Leprosum | July 2010 | July 2013 |
| NCT00919776 | Completed | Phase 2 | Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum | August 2010 | July 2013 |
| NCT00919815 | Completed | Phase 2/Phase 3 | Ciclosporin in the Management of New Type 1 Reactions in Leprosy | August 2010 | July 2013 |
| NCT00920660 | Completed | Phase 1 | Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy Volunteers | April 6, 2009 | June 12, 2009 |
| NCT00920933 | Completed | Phase 1/Phase 2 | Effect of AIN457 on Ozone-induced Airway Neutrophilia Compared to Placebo and Corticosteroid in Healthy Subjects | January 2009 | |
| NCT00971724 | Completed | N/A | Biomarkers of Prednisolone Treatment (P05888) | May 2006 | March 2008 |
| NCT00971763 | Completed | Phase 2 | Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma | March 2006 | July 2011 |
| NCT00982072 | Completed | Phase 4 | Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease | December 2009 | October 10, 2019 |
| NCT00985959 | Completed | Phase 1 | A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT) | July 2008 | June 2010 |
| NCT01014221 | Completed | N/A | Acupuncture in Patients With Carpal Tunnel Syndrome ~ A Randomized Controlled Trial | July 2007 | September 2009 |
| NCT01088750 | Completed | Phase 4 | Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma | November 1, 2009 | October 31, 2023 |
| NCT01134432 | Completed | Phase 3 | Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia | March 2005 | July 2012 |
| NCT01140932 | Completed | N/A | The Electroretinogram in Healthy and Glucose Intolerant Young Men | February 2010 | June 2010 |
| NCT01185197 | Completed | Phase 4 | Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study | September 2010 | June 2017 |
| NCT01272635 | Completed | Phase 3 | Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids. | March 2011 | January 2015 |
| NCT01275638 | Completed | Phase 4 | The Effect of Moderate-Dose Steroid Therapy in Sepsis | April 2005 | May 2009 |
| NCT01276314 | Completed | N/A | Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions | January 2009 | May 2015 |
| NCT01299948 | Completed | Phase 2 | Progression of HIV-Disease Under Low Dose Corticosteroids | June 2007 | May 2012 |
| NCT01324583 | Completed | Phase 1 | Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer | January 2011 | November 2014 |
| NCT01353235 | Completed | Phase 3 | Oral Prednisolone in Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) | April 2010 | June 2013 |
| NCT01369745 | Completed | Phase 2 | A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis | June 2011 | September 2012 |
| NCT01395251 | Completed | Phase 2/Phase 3 | Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis | February 2012 | December 2014 |
| NCT01485861 | Completed | Phase 1/Phase 2 | Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy | January 11, 2012 | August 31, 2022 |
| NCT01539083 | Completed | Phase 3 | Velcade (Bortezomib) Consolidation After Transplant | January 13, 2012 | January 9, 2018 |
| NCT01619163 | Completed | Phase 4 | Prednisolone for Pain Reduction in Knee OA | November 2011 | January 2012 |
| NCT01621321 | Completed | Phase 2/Phase 3 | Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis | June 2013 | April 2016 |
| NCT01679119 | Completed | Phase 2 | Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy | October 2013 | March 2022 |
| NCT01685983 | Completed | Phase 2 | A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer | August 30, 2011 | March 6, 2018 |
| NCT01756638 | Completed | Phase 2 | A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer | June 6, 2012 | October 17, 2014 |
| NCT01762787 | Completed | Phase 1 | Phase I Methodology Study to Validate the Cantharidin Blister Model in Healthy Volunteers | August 17, 2010 | January 14, 2011 |
| NCT01763580 | Completed | Phase 4 | A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome | July 16, 2012 | August 21, 2017 |
| NCT01795703 | Completed | Phase 2 | A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel | June 2012 | October 2014 |
| NCT01828437 | Completed | Phase 3 | Addition of Pyridoxine to Prednisolone in Infantile Spasms | November 2012 | March 2014 |
| NCT01897571 | Completed | Phase 1/Phase 2 | Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL | June 13, 2013 | November 2, 2021 |
| NCT01903798 | Completed | Phase 2 | A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis | December 2014 | April 2016 |
| NCT01908972 | Completed | Phase 4 | The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma | June 2013 | May 2015 |
| NCT01948401 | Completed | Phase 2 | A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent Asthma | July 2013 | April 2014 |
| NCT01992653 | Completed | Phase 1/Phase 2 | A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma | November 29, 2013 | December 19, 2018 |
| NCT02000336 | Completed | Phase 3 | Comparison of the Effectiveness of Two Different Dosages of Cortisone Compared to Placebo in Rheumatoid Arthritis | January 2014 | September 2019 |
| NCT02028754 | Completed | Phase 4 | A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms | July 2011 | May 2013 |
| NCT02074137 | Completed | Phase 4 | Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer | July 2014 | March 2016 |
| NCT02077556 | Completed | Phase 4 | Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients | April 2014 | January 15, 2019 |
| NCT02167217 | Completed | Phase 2 | Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy | April 17, 2014 | March 22, 2017 |
| NCT02229136 | Completed | Phase 2 | Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus | September 4, 2014 | November 2022 |
| NCT02265328 | Completed | Phase 2 | Efficacy of Combination Therapy of Glucocorticoids and Bovine Colostrum in Treatment of Severe Alcoholic Hepatitis. | September 2014 | June 2015 |
| NCT02281929 | Completed | Phase 3 | Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone | June 13, 2015 | November 19, 2019 |
| NCT02288247 | Completed | Phase 3 | A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone | December 1, 2014 | March 13, 2024 |
| NCT02375867 | Completed | Phase 4 | Steroids in Fulminant Hepatitis A in the Pediatric Age Group | January 2015 | September 2017 |
| NCT02405858 | Completed | Phase 4 | A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy | April 10, 2015 | December 31, 2017 |
| NCT02425852 | Completed | Phase 4 | A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis | December 2016 | January 2023 |
| NCT02441894 | Completed | Phase 4 | Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer | April 2015 | November 2016 |
| NCT02512575 | Completed | Phase 1 | A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567. | November 18, 2015 | September 26, 2016 |
| NCT02517684 | Completed | Phase 4 | Top-down Infliximab Study in Kids With Crohn's Disease | April 2015 | January 2024 |
| NCT02547623 | Completed | Phase 3 | Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery | November 6, 2015 | August 16, 2016 |
| NCT02585258 | Completed | Phase 4 | The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study | June 30, 2016 | December 31, 2020 |
| NCT02587117 | Completed | Phase 4 | A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral Lichen Planus | February 2013 | March 2014 |
| NCT02629042 | Completed | Phase 3 | Efficacy of Oral Prednisolone on Pain Reduction in Emergency Care of Acute Irreversible Pulpitis | May 15, 2017 | December 3, 2018 |
| NCT02644499 | Completed | Phase 4 | Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid Arthritis | December 31, 2015 | September 15, 2017 |
| NCT02670616 | Completed | Phase 2 | Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma | May 1, 2016 | October 2020 |
| NCT02686619 | Completed | Phase 3 | Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients | November 2004 | January 2011 |
| NCT02819648 | Completed | Phase 4 | Oral Glucocorticoids Effect on Post Endodontic Pain | June 2012 | June 2016 |
| NCT02854631 | Completed | Phase 2 | Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH) | September 1, 2016 | May 31, 2018 |
| NCT02855502 | Completed | Phase 4 | Investigation of the Effect of Systemic Steroids on Treatment and Prevention of Recurrent Tracheal Stenosis in Postoperative Patients | November 2014 | December 2016 |
| NCT02857842 | Completed | Phase 4 | Corticosteroid Reduction in COPD | August 2016 | January 2019 |
| NCT02949349 | Completed | Phase 2 | Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis | July 2015 | January 25, 2017 |
| NCT03141970 | Completed | Phase 3 | Prednisolone Trial in Children Younger Than 4 Years | July 1, 2015 | October 31, 2021 |
| NCT03156452 | Completed | Phase 3 | Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate | October 25, 2017 | March 5, 2020 |
| NCT03172325 | Completed | Phase 3 | Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA | November 18, 2015 | January 4, 2017 |
| NCT03188068 | Completed | Phase 2 | Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma | June 1, 2017 | December 31, 2021 |
| NCT03198013 | Completed | Phase 1 | A Study of Pharmacokinetics (PK) and Pharmacodynamics (PD) in Relation to Prednisolone in Healthy Males | November 11, 2008 | May 18, 2009 |
| NCT03298061 | Completed | Phase 3 | Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921 | April 14, 2015 | February 16, 2023 |
| NCT03368235 | Completed | Phase 2 | Early Phase Study to Assess Efficacy and Safety of AZD9567 Versus Prednisolone in Patients With Rheumatoid Arthritis | January 18, 2018 | November 12, 2019 |
| NCT03503227 | Completed | Phase 2/Phase 3 | The Value of Prednisolone With Aspirin Before Embryo Transfer in Intracytoplasmic Sperm Injection (ICSI) Cycles | April 23, 2018 | October 31, 2018 |
| NCT03585829 | Completed | Phase 4 | Ramadan Fasting in Patients With Corticotrope Deficiency Treated Either by Hydrocortisone or by Prednisolone | May 17, 2018 | July 25, 2018 |
| NCT03610685 | Completed | Phase 4 | Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma | October 19, 2018 | January 7, 2020 |
| NCT03705884 | Completed | N/A | PET/MR Imaging In Patients With Cardiac Sarcoidosis | October 30, 2017 | December 1, 2018 |
| NCT03765788 | Completed | Phase 2 | A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis | January 30, 2019 | June 8, 2021 |
| NCT03834519 | Completed | Phase 3 | Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010) | May 2, 2019 | January 27, 2024 |
| NCT04071262 | Completed | Phase 1 | A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer | December 20, 2019 | August 30, 2021 |
| NCT04146220 | Completed | Phase 4 | Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis | July 16, 2018 | September 30, 2019 |
| NCT04458636 | Completed | Phase 4 | Stratified TreAtment to Reduce Risk in COPD | November 2, 2017 | April 30, 2020 |
| NCT04556760 | Completed | Phase 2 | Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes | November 26, 2020 | June 9, 2021 |
| NCT04652739 | Completed | Phase 2/Phase 3 | Evaluation of Lycopene in the Treatment of Erosive Oral Lichen Planus | October 1, 2018 | March 10, 2019 |
| NCT04765371 | Completed | Phase 3 | Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, With CoViD-19 | March 3, 2021 | February 10, 2022 |
| NCT04767711 | Completed | N/A | Prevention of Glucocorticoid Induced Impairment of Bone Metabolism | May 16, 2022 | December 15, 2022 |
| NCT05003089 | Completed | Phase 1 | A Trial to Learn How BAY1834845 and BAY1830839 Affect Inflammation When Taken by Mouth Twice a Day for 7 Days in a Row in Healthy Male Participants | June 28, 2021 | January 20, 2022 |
| NCT05328414 | Completed | Phase 1/Phase 2 | Preparation and Characterization Intranasal Film Loaded With Steroid as a Local Treatment of Anosmia in Compare to Insulin Intranasal Film | March 1, 2022 | May 20, 2023 |
| NCT05850143 | Enrolling by invitation | N/A | EFFECTIVENESS OF SINGLE DOSE ORAL DEXAMETHASONE VERSUS MULTIDOSE PREDNISOLONE FOR TREATMENT OF ACUTE EXACERBATIONS OF ASTHMA AMONG CHILDREN ATTENDING THE EMERGENCY DEPARTMENT OF CHILDREN HOSPITAL, ISLAMABAD | January 26, 2019 | December 26, 2023 |
| NCT06320067 | Not yet recruiting | Phase 3 | A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer | April 2024 | March 2034 |
| NCT04736108 | Not yet recruiting | Phase 2 | Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate | May 2021 | December 2024 |
| NCT06155760 | Not yet recruiting | N/A | Role of Extended Low Dose Prednisolone in Achieving Clinical and Biochemical Remission in Steroid Responsive Severe Alcoholic Hepatitis | November 25, 2023 | February 27, 2025 |
| NCT06260904 | Not yet recruiting | Phase 4 | Efficacy and Safety of add-on Apremilast Versus add-on Methotrexate in Patients With Oral Lichen Planus | February 26, 2024 | May 31, 2025 |
| NCT06317662 | Not yet recruiting | Phase 2 | Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia | July 31, 2024 | December 21, 2027 |
| NCT05694130 | Not yet recruiting | Phase 2/Phase 3 | Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS | February 2023 | December 2024 |
| NCT06421597 | Not yet recruiting | Phase 2 | Identifying Individuals at Risk of Glucocorticoid-Induced Impairment of Bone Disease | May 2024 | December 2025 |
| NCT06145126 | Not yet recruiting | N/A | Effects of Glucocortioids in Human Skeletal Muscle, Adipose Tissue and Skin | December 2023 | July 2025 |
| NCT06220032 | Not yet recruiting | Phase 3 | Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma | May 21, 2024 | December 15, 2028 |
| NCT06124157 | Not yet recruiting | Phase 3 | A Study Comparing the Combination of Dasatinib and Chemotherapy Treatment With or Without Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or Philadelphia Chromosome-Like (Ph-Like) ABL-Class B-Cell Acute Lymphoblastic Leukemia (B-ALL) | July 22, 2024 | December 1, 2030 |
| NCT05990985 | Not yet recruiting | N/A | The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission. | September 1, 2023 | August 1, 2026 |
| NCT04797325 | Recruiting | Phase 2 | Vedolizumab for Immune Mediated Colitis | August 30, 2021 | April 2025 |
| NCT05821075 | Recruiting | Phase 1/Phase 2 | Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy | April 24, 2023 | December 2024 |
| NCT04043494 | Recruiting | Phase 3 | International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma | August 23, 2019 | November 22, 2027 |
| NCT05861440 | Recruiting | N/A | Applying Shear Wave Elastography for Adjunct Steroid on Tuberculous Lymphadenitis | May 2023 | December 2025 |
| NCT06174922 | Recruiting | Phase 3 | A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis | December 1, 2023 | March 2026 |
| NCT04078568 | Recruiting | Phase 3 | Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease | January 15, 2020 | September 2025 |
| NCT05947669 | Recruiting | Phase 3 | Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis | August 22, 2023 | September 2028 |
| NCT05619653 | Recruiting | Phase 3 | Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19 | December 12, 2022 | December 31, 2028 |
| NCT06188676 | Recruiting | Phase 3 | Multicenter Study of Safety and Efficacy Nivolumab at the Fixed Dose 40 mg (Nivo40) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed PMBL | April 1, 2022 | April 1, 2029 |
| NCT05626387 | Recruiting | Phase 4 | An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis | November 23, 2022 | October 23, 2025 |
| NCT03206671 | Recruiting | Phase 3 | Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents | August 3, 2017 | August 2024 |
| NCT05105256 | Recruiting | N/A | Platelet-rich Plasma Infiltration Versus Corticosteroid Infiltration (Prednisolone) in Treatment of Lumbar Facet Joint Syndrome | December 21, 2021 | December 21, 2024 |
| NCT04300556 | Recruiting | Phase 1/Phase 2 | A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types | August 6, 2020 | March 31, 2025 |
| NCT03286634 | Recruiting | Phase 2 | ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 | April 18, 2017 | March 31, 2033 |
| NCT05961202 | Recruiting | Phase 2/Phase 3 | The Effects of Hydroxychloroquine in Patients With Inflammatory Cardiomyopathy | January 1, 2022 | June 1, 2025 |
| NCT04423926 | Recruiting | Phase 1/Phase 2 | Lenalidomide in Combination With CHOP in Patients With Untreated PTCL | June 10, 2020 | December 31, 2024 |
| NCT05725512 | Recruiting | Phase 4 | Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages | January 29, 2024 | July 29, 2027 |
| NCT03007147 | Recruiting | Phase 3 | Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | August 8, 2017 | September 30, 2027 |
| NCT04862221 | Recruiting | Phase 2 | TReatment for ImmUne Mediated PathopHysiology | February 9, 2022 | January 31, 2027 |
| NCT03899337 | Recruiting | Phase 2 | A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome | July 23, 2019 | May 31, 2027 |
| NCT03902912 | Recruiting | Phase 3 | Effect of Prednisolone Treatment on Uterine Natural Killer Cells | July 30, 2019 | April 30, 2028 |
| NCT03914625 | Recruiting | Phase 3 | A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia | July 3, 2019 | June 30, 2029 |
| NCT03933631 | Recruiting | Phase 3 | Pilocarpine Use After Kahook Goniotomy | May 1, 2019 | December 2025 |
| NCT03942887 | Recruiting | Phase 3 | Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis | May 3, 2019 | April 1, 2025 |
| NCT03958344 | Recruiting | Phase 3 | Intraorbital Injection Versus Oral Steroid in Anterior Idiopathic Orbital Inflammation | January 1, 2022 | June 1, 2025 |
| NCT03959085 | Recruiting | Phase 3 | Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy | October 31, 2019 | March 31, 2030 |
| NCT05570409 | Recruiting | Phase 2/Phase 3 | Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy | March 28, 2023 | March 28, 2028 |
| NCT05781516 | Recruiting | N/A | Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RD | January 20, 2023 | June 2025 |
| NCT04479267 | Recruiting | Phase 2 | Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma | August 21, 2020 | November 15, 2026 |
| NCT05639127 | Recruiting | Early Phase 1 | The Treatment of Adrenal Crisis With Inhaled Prednisolone | November 3, 2022 | March 1, 2023 |
| NCT04610476 | Recruiting | Phase 3 | Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis | October 19, 2020 | October 19, 2025 |
| NCT06281236 | Recruiting | Phase 1 | A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR) | February 22, 2024 | October 1, 2024 |
| NCT05675410 | Recruiting | Phase 3 | A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab | May 11, 2023 | April 28, 2031 |
| NCT04759586 | Recruiting | Phase 3 | Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma | October 5, 2021 | September 30, 2027 |
| NCT05984381 | Recruiting | Phase 4 | Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid | August 1, 2023 | December 1, 2024 |
| NCT06336395 | Recruiting | Phase 2 | Ma-Spore ALL 2020 Study | March 4, 2020 | March 2030 |
| NCT05406401 | Recruiting | Phase 2 | A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007) | July 14, 2022 | January 26, 2026 |
| NCT05776459 | Recruiting | Phase 2 | Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) | October 13, 2022 | December 30, 2024 |
| NCT05749666 | Recruiting | Phase 3 | Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis | January 20, 2023 | July 20, 2025 |
| NCT05761171 | Recruiting | Phase 2 | A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia | January 8, 2024 | December 31, 2027 |
| NCT06035081 | Recruiting | N/A | CIRcadian Rhythms and CortisoL. Effects on Substrate Metabolism and Clock Gene Expression and Functioning | September 15, 2023 | March 2024 |
| NCT05412394 | Recruiting | Phase 4 | Once Weekly Infant Corticosteroid Trial for DMD | April 30, 2021 | December 30, 2026 |
| NCT05510323 | Recruiting | Phase 3 | Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD | February 1, 2024 | August 2028 |
| NCT04873583 | Recruiting | Phase 3 | High Dose Steroids in Children With Stroke | November 16, 2021 | July 2026 |
| NCT03643276 | Recruiting | Phase 3 | Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 | July 15, 2018 | July 14, 2028 |
| NCT06143891 | Recruiting | Phase 3 | A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. | January 23, 2024 | September 29, 2028 |
| NCT03775460 | Recruiting | N/A | Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum | January 15, 2023 | December 1, 2024 |
| NCT03781700 | Recruiting | Phase 4 | Evaluation of Cortisone Treatment in Children With Acute Facial Nerve Palsy | May 3, 2019 | December 31, 2026 |
| NCT02631603 | Suspended | Phase 2 | Stop Exogenous Allergic Alveolitis (EAA) in Childhood | April 2015 | April 2024 |
| NCT00327197 | Terminated | Phase 1 | Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma | August 2, 2005 | June 6, 2011 |
| NCT02912182 | Terminated | Phase 4 | Acute Unilateral Vestibulopathy and Corticosteroid Treatment | December 2015 | March 1, 2021 |
| NCT04315350 | Terminated | N/A | The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance | December 1, 2019 | June 11, 2021 |
| NCT02930343 | Terminated | Phase 3 | Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy | September 2016 | August 2018 |
| NCT02935101 | Terminated | Phase 2 | Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants | October 2016 | May 2017 |
| NCT02686385 | Terminated | N/A | Efficacy of N-acetylcysteine With or Without Steroids in Drug Induced Liver Injury | March 1, 2016 | August 31, 2016 |
| NCT04780464 | Terminated | Phase 3 | A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma | April 11, 2022 | November 11, 2023 |
| NCT01370694 | Terminated | Phase 1 | Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001) | August 19, 2011 | December 1, 2014 |
| NCT00796250 | Terminated | Phase 3 | Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732) | November 1, 2003 | January 1, 2005 |
| NCT00637832 | Terminated | Phase 2 | Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma | April 1, 2008 | January 6, 2015 |
| NCT03340909 | Terminated | Phase 2 | The Norwegian Prednisolone in Early Psychosis Study | February 2, 2018 | December 31, 2021 |
| NCT00275106 | Terminated | Phase 3 | Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma | September 2004 | August 2012 |
| NCT00521989 | Terminated | Phase 2 | CRx-102 Osteoarthritis Multicenter Evaluation Trial | August 2007 | July 2009 |
| NCT03777319 | Terminated | Phase 1 | Spironolactone Versus Prednisolone in DMD | December 5, 2018 | November 30, 2021 |
| NCT01211665 | Terminated | Phase 4 | Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS) | September 2010 | February 2012 |
| NCT01179490 | Terminated | Phase 2 | Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma | September 2010 | |
| NCT02949232 | Terminated | Phase 4 | Prednisolone Addition for Patients With Recent-onset Psychotic Disorder | July 2014 | May 2019 |
| NCT00331058 | Terminated | Phase 1 | Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects | February 18, 2006 | July 7, 2011 |
| NCT02125617 | Terminated | Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer | January 2014 | February 2017 | |
| NCT02162810 | Terminated | N/A | Effect of Steroids on Post-Operative Complications Following Proximal Hypospadias Repair | May 2014 | May 2022 |
| NCT00984568 | Terminated | Phase 3 | Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553) | November 2009 | March 2012 |
| NCT00967226 | Terminated | Phase 2 | Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas | July 2009 | December 2014 |
| NCT00003437 | Unknown status | Phase 3 | Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia | January 1997 | |
| NCT05341401 | Unknown status | Phase 2/Phase 3 | Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis | June 2022 | June 2024 |
| NCT05369039 | Unknown status | Phase 2 | Roflumilust in Chronic Rhinosinusitis With Nasal Polyposis. | June 2022 | March 2023 |
| NCT02618057 | Unknown status | Phase 4 | Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia | June 2016 | December 2020 |
| NCT02662283 | Unknown status | Phase 2/Phase 3 | Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy | May 2016 | November 2016 |
| NCT02695797 | Unknown status | Phase 4 | Immunotherapy in Intractable Cryptogenic Epilepsy Patients With Autoimmune Antibody | September 2015 | December 2016 |
| NCT00317408 | Unknown status | N/A | Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma | April 2004 | |
| NCT00244166 | Unknown status | Phase 2/Phase 3 | Prednisolone in Active Ankylosing Spondylitis (AS) | May 2002 | August 2008 |
| NCT02894645 | Unknown status | Phase 4 | Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study | October 2008 | |
| NCT03067753 | Unknown status | Phase 2 | Monosialoganglioside Ganglioside in Cerebral Radiation Necrosis | December 2016 | September 2019 |
| NCT00343369 | Unknown status | N/A | Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia | January 2003 | |
| NCT03200561 | Unknown status | Phase 3 | A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study) | October 17, 2013 | December 31, 2020 |
| NCT00416377 | Unknown status | N/A | Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma | ||
| NCT00417014 | Unknown status | N/A | Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma | ||
| NCT00131053 | Unknown status | Phase 2 | Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL) | September 2002 | September 2011 |
| NCT03303053 | Unknown status | Phase 3 | Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism | May 11, 2017 | March 1, 2018 |
| NCT00494624 | Unknown status | Phase 4 | Efficacy of Systemic Glucocorticoid in the Treatment of Wheezing in Children | September 2000 | May 2008 |
| NCT03352115 | Unknown status | N/A | Postoperative Oral Corticosteroids Following Tonsillectomy | January 2018 | January 2019 |
| NCT00539565 | Unknown status | Phase 3 | RCT of Steroids Following Kasai Portoenterostomy for Biliary Atresia. | January 2000 | September 2008 |
| NCT00550992 | Unknown status | N/A | Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia | January 2006 | |
| NCT00131027 | Unknown status | Phase 3 | High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) | September 2002 | September 2011 |
| NCT00562068 | Unknown status | Phase 1 | Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma | May 2007 | |
| NCT03576794 | Unknown status | Phase 3 | Treatment With Leflunomide in Patients With Polymyalgia Rheumatica | March 1, 2019 | November 1, 2022 |
| NCT00609752 | Unknown status | Phase 4 | Adverse Effects of Glucocorticoid Therapy on Bone in Childhood Crohn's Disease | February 2008 | January 2010 |
| NCT00002531 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia | January 1993 | |
| NCT00032149 | Unknown status | Phase 1/Phase 2 | Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | October 2001 | |
| NCT00669812 | Unknown status | Phase 2 | High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma | February 2008 | |
| NCT00687648 | Unknown status | Phase 2 | Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer | May 2008 | |
| NCT00689845 | Unknown status | N/A | Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma | June 2007 | |
| NCT00723268 | Unknown status | Phase 2 | Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae | May 2007 | |
| NCT00731575 | Unknown status | N/A | Viral Inception of Asthma: Prospective Study From Infancy to School-age | June 2007 | |
| NCT00778596 | Unknown status | Phase 4 | Prednisolone Priming Study in Patients With Chronic Hepatitis B | February 2009 | December 2013 |
| NCT00031902 | Unknown status | Phase 1 | Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | October 2001 | |
| NCT00890253 | Unknown status | Phase 2 | Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation | January 2010 | January 2013 |
| NCT00025064 | Unknown status | Phase 2 | Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma | January 2000 | |
| NCT01005758 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | January 2009 | |
| NCT00003815 | Unknown status | Phase 3 | Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | June 1994 | |
| NCT03967925 | Unknown status | Phase 2 | Rituximab and Belimumab Combination Therapy in PR3 Vasculitis | February 1, 2019 | November 2023 |
| NCT01095172 | Unknown status | Phase 4 | RituxiMab INDuction in Renal Transplantation | November 2010 | October 2022 |
| NCT00003728 | Unknown status | Phase 3 | Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma | December 1998 | |
| NCT01201642 | Unknown status | N/A | Prednisone and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, CER in China | September 2010 | April 2015 |
| NCT04066179 | Unknown status | N/A | Efficacy of Monotherapy vs Combination Therapy of Corticosteroids With GCSF in Severe Alcoholic Hepatitis Patients. | September 7, 2019 | February 27, 2021 |
| NCT00003603 | Unknown status | Phase 3 | Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma | March 1998 | |
| NCT01303887 | Unknown status | Phase 3 | A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients | October 2009 | September 2016 |
| NCT02373137 | Unknown status | Phase 4 | Descemet Endothelial Thickness Comparison Trial | January 22, 2015 | May 30, 2023 |
| NCT04181489 | Unknown status | Phase 2 | Sintilimab in Combination With R-CHOP in Patients With Treatment-naive EBV-positive DLBCL, NOS | January 1, 2019 | December 30, 2023 |
| NCT00003423 | Unknown status | Phase 3 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | May 1995 | |
| NCT01455337 | Unknown status | Phase 3 | Short-term Survival in Patients With Severe Alcoholic Hepatitis Treated With Steroid Versus Pentoxifylline | January 2009 | December 2011 |
| NCT00002987 | Unknown status | Phase 3 | Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease | January 1997 | |
| NCT01550445 | Unknown status | Phase 4 | Steroid Withdrawal Immunosuppression After Renal Transplantation | May 2008 | July 2012 |
| NCT01719835 | Unknown status | Phase 2 | CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study | March 2012 | August 2022 |
| NCT04481971 | Unknown status | Phase 2 | A Comparison of Two Different Single Doses of Prednisolone on Endodontic Inter-appointment Pain | August 9, 2020 | December 31, 2020 |
| NCT01884428 | Unknown status | Phase 1 | Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma | July 2011 | December 2015 |
| NCT04713410 | Unknown status | N/A | Comparison of Relapse Rate After 12 Weeks Verses 20 Weeks Steroid Therapy for the Management of First Episode of Steroid Sensitive Nephrotic Syndrome | December 22, 2020 | September 4, 2023 |
| NCT04733144 | Unknown status | Phase 1 | Bioequivalence Study of Prednisolone and Dexamethasone | March 4, 2021 | May 31, 2022 |
| NCT00002532 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia | January 1993 | |
| NCT05143502 | Unknown status | Phase 1/Phase 2 | Role of Montelukast in the Management of Chronic Rhinosinusitis With Nasal Polyps. | January 1, 2022 | March 1, 2024 |
| NCT04005079 | Withdrawn | Phase 3 | Pilocarpine After Combined Cataract/Trabectome Surgery | June 5, 2019 | January 21, 2021 |
| NCT00900445 | Withdrawn | Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia | March 24, 2008 | ||
| NCT00539799 | Withdrawn | Phase 3 | Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis | ||
| NCT03087968 | Withdrawn | Early Phase 1 | Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124 | July 31, 2016 | September 13, 2017 |
| NCT02904772 | Withdrawn | Phase 2 | Alipogene Tiparvovec for the Treatment of LPLD Patients | October 2016 | September 2020 |
| NCT02299115 | Withdrawn | Phase 3 | Prednisolone Versus Vigabatrin in the First-line Treatment of Infantile Spasms | September 5, 2017 | March 6, 2019 |
| NCT05320380 | Withdrawn | Phase 1/Phase 2 | A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat | August 1, 2023 | September 1, 2023 |
| NCT05300490 | Withdrawn | Prednisolone Urinary Excretion Kinetics | May 2023 | January 1, 2024 | |
| NCT02004782 | Withdrawn | Phase 4 | Barretts oEsophageal Resection With Steroid Therapy Trial | March 2022 | June 2022 |
| NCT04536181 | Withdrawn | Phase 3 | Study of Initial Steroid Treatment in Young Children With Nephrotic Syndrome | January 1, 2021 | October 1, 2022 |